Want to see JP:3633 full AI Analyst Report?
GMO Pepabo, Inc. (3633) AI Stock Analysis
GMO Pepabo, Inc.
(TSE/TYO:3633)
GMO Pepabo achieves a strong score of 82, driven primarily by its highly compelling valuation and stellar cash flow generation. The company boasts a pristine, low-leverage balance sheet and rewards investors with a solid dividend yield at a low earnings multiple. Powerful technical momentum further supports the stock's near-term strength. The most notable headwind constraining a higher score is the company's stagnant top-line revenue growth.
GMO Pepabo, Inc. (3633) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 12.19B
- Dividend Yield
- 2.84%
- Average Volume (3M)
- 31.10K
- Price to Earnings (P/E)
- 7.8
- Beta (1Y)
- 0.53
- Revenue Growth
- -3.72%
- EPS Growth
- 138.33%
- Country
- Japan
- Employees
- 307
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Infrastructure
GMO Pepabo, Inc. Business Overview & Revenue Model
Company Description
GMO Pepabo, Inc. delivers a variety of internet-based services tailored for individual consumers across Japan. The firm organizes its activities into four core divisions. Its Hosting segment supplies foundational services, including domain registrati...
GMO Pepabo, Inc. Financial Statement Overview
Summary
GMO Pepabo exhibits excellent financial health with a deleveraged balance sheet and robust free cash flow conversion (94% of net income). However, the score is tempered by slightly negative revenue growth (-1.2%), indicating a strategic focus on profitability and efficiency rather than top-line expansion.
Income Statement
62PositiveBalance Sheet
78PositiveCash Flow
82Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.83B | 10.96B | 10.92B | 10.90B | 10.53B | 11.88B |
| Gross Profit | 5.84B | 5.96B | 5.78B | 5.93B | 6.08B | 6.73B |
| EBITDA | 1.68B | 1.44B | 1.47B | 84.16M | 1.12B | 1.36B |
| Net Income | 829.77M | 878.44M | 591.63M | -628.79M | 510.09M | 715.41M |
Balance Sheet | ||||||
| Total Assets | 10.67B | 11.32B | 11.47B | 10.95B | 11.52B | 8.91B |
| Cash, Cash Equivalents and Short-Term Investments | 2.02B | 5.75B | 4.92B | 4.36B | 3.61B | 3.62B |
| Total Debt | 400.00M | 857.45M | 1.19B | 1.48B | 1.57B | 172.15M |
| Total Liabilities | 8.24B | 8.52B | 9.08B | 9.14B | 8.83B | 5.96B |
| Stockholders Equity | 2.43B | 2.80B | 2.39B | 1.81B | 2.69B | 2.93B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 1.37B | 901.23M | 1.38B | -708.88M | 338.84M |
| Operating Cash Flow | 0 | 1.46B | 1.21B | 1.78B | -213.40M | 669.08M |
| Investing Cash Flow | 0 | 236.62M | -292.00M | -325.63M | -510.15M | -278.35M |
| Financing Cash Flow | 0 | -859.23M | -361.39M | -702.63M | 712.28M | -392.52M |
GMO Pepabo, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3633, the sentiment is Neutral. The current price of 2321.00 is below the 20-day moving average (MA) of 2563.50, below the 50-day MA of 2552.48, and above the 200-day MA of 2042.17, indicating a neutral trend. The MACD of -39.73 indicates Positive momentum. The RSI at 34.93 is Neutral, neither overbought nor oversold. The STOCH value of 17.87 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3633.
GMO Pepabo, Inc. Peers Comparison
Overall Rating
JP:443183Outperform- JP:363382Outperform
JP:376969Neutral
JP:443462Neutral
JP:366559Neutral
JP:377845Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4431 | 83Outperform | JPY 74.15B | 28.79 | ― | 0.63% | 20.70% | 56.44% |
| JP:3633 | 82Outperform | JPY 12.50B | 7.84 | ― | 2.84% | -3.72% | 138.33% |
| JP:3769 | 69Neutral | JPY 649.44B | 25.77 | 21.67% | 1.99% | 13.19% | 25.73% |
| JP:4434 | 62Neutral | JPY 22.31B | 18.98 | ― | 1.43% | 23.79% | ― |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| JP:3665 | 59Neutral | JPY 17.07B | 70.20 | ― | 7.32% | -1.71% | -7.98% |
| JP:3778 | 45Neutral | JPY 121.34B | 44.23 | ― | 0.16% | 25.84% | 71.45% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:3633 | GMO Pepabo, Inc. | 2362.00 | 373.27 | 18.77% | |
| JP:3769 | GMO Payment Gateway | 8563.00 | 298.98 | 3.62% | |
| JP:3665 | ENIGMO, Inc. | 410.00 | 25.06 | 6.51% | |
| JP:3778 | SAKURA Internet Inc. | 3035.00 | -293.64 | -8.82% | |
| JP:4431 | Smaregi, Inc. | 3790.00 | 969.30 | 34.36% | |
| JP:4434 | Serverworks Co., Ltd. | 2801.00 | 934.23 | 50.05% |
GMO Pepabo, Inc. Corporate Events
GMO Pepabo Lifts 2026 Profit Outlook and Dividend on Tax Benefit From Subsidiary Liquidation
GMO Pepabo, Inc. announced it will recognize an income tax benefit in the fiscal year ending December 31, 2026, stemming from deferred tax assets related to the special liquidation of consolidated subsidiary CN Co., Ltd. This tax effect significantly...
GMO Pepabo Lifts Profit Outlook Despite Lower First-Half Sales
GMO Pepabo reported consolidated net sales of ¥5.26 billion for the six months ended June 30, 2026, down 5.0% year on year, with operating profit falling 14.1% to ¥513 million but profit attributable to owners of parent surging 169.5% to &#...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 18, 2026